ROMI's Website

Please use your "back" browser to return to the Main/Navigation page or click here: http://rimadyldeath.com. 


You are at the ADVERTISING vs YOUR LIFE/HEALTH page


If you are on this page, you are probably already familiar with what's currently taking place in the drug industry

Another "industry" has now jumped onto the bandwagon in the middle of this "health/safety" crisis.  Is it "drumming up business" or "drumming up DEATH"?

YOU be the judge, after all it's only YOUR life and that of your loved ones that's at stake!


Tough Times Ahead for Cox-2 Inhibitors; Demonstrating Safety is Crucial


PALO ALTO, Calif.--(BUSINESS WIRE)----With the recent recall of Vioxx, a critical challenge facing the Cox-2 inhibitor markets in the United States is the need to conclusively demonstrate the safety of these drugs in long-term use.

New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Vioxx Recall: Revenue Analysis and Impact on Cox-2 Inhibitor Markets, reveals through its pessimistic forecasts that this market generated revenue of $3.6 billion in 2004. Total market revenues expect to decrease to $3.13 billion in 2010.

If you are interested in a virtual brochure, which provides manufacturers, end-users and other industry participants an overview of the latest analysis of the Vioxx Recall: Revenue Analysis and Impact on Cox-2 Inhibitor Markets - then send an email to Danielle White - Corporate Communications at dwhite@frost.com with the following information: your full name, company name, title, telephone number, fax number, and email. Upon receipt of the above information, an overview will be sent to you via e-mail.

The drug was voluntarily recalled after data from a clinical trial revealed those it-increased patients' risks of getting heart attacks and strokes.  Proving the safety of other Cox-2 inhibitors in long-term use is, therefore, likely to be a difficult task.

"Post recall, gaining the approval of the Food and Drug Administration (FDA) for new Cox-2 inhibitors is likely to be a long-drawn out process," says Frost & Sullivan Research Analyst Elisa Perez. "The FDA may even require additional information that will prolong the return on investment (ROI) for these products."

Extensive clinical trials are necessary to demonstrate the safety of using Cox-2 inhibitors over a prolonged period of time. While these trials will involve additional expenses, they are essential if companies hope to gain the required FDA approval and successfully penetrate the market.

The market also faces the challenge of getting physicians and patients to accept these drugs for use as pain management therapies.

"Physicians' reluctance to prescribe Cox-2 inhibitors for pain therapy is increasing," remarks Perez. "A growing amount of data - suggesting that other Cox-2 inhibitors may also carry the risk of cardiovascular adverse effects - is likely to further hurt this market as physicians and patients look to over-the-counter (OTC) products or traditional non-steroidal anti-inflammatory drugs (NSAIDs) for pain management."

." Removing the stigma associated with the adverse side effects of Vioxx, and potentially other Cox-2 inhibitors as well, will require companies to adopt aggressive marketing strategies targeted at physicians as well as patients. Physician education will help in increasing their prescriptions of these therapies, which in turn will make patients more amenable to using them.

"With the recall of Vioxx having impacted not only the Cox-2 inhibitor markets, but also the pharmaceuticals industry as a whole, patient and physician education is critical," remarks Perez. "Pharmaceutical companies should work closely with the FDA to determine the best strategy in the event of recall of a drug. Clinical trials to ensure long-term efficacy and safety are very important for the success of a drug."

Vioxx Recall: Revenue Analysis and Impact on Cox-2 Inhibitor Markets, part of the Pharmaceuticals (9611) subscription, which also includes market insights on Pharmaceutical Strategic Snapshots (9651), analyzes the impact of recall of the drug, Vioxx, on the Cox-2 inhibitor markets. This thorough analysis includes physicians' perspectives that are expected to give pharmaceutical companies a new depth of information on measures to counter the effects of recall. The research discusses the impact of the recall in terms of revenue and patient forecasts and physicians' past and future prescription trends. Executive summaries and interviews are available to the press.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. Its advisory expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities for clients. While serving clientele ranging from virtually every Global 1000 to emerging companies, Frost & Sullivan's comprehensive industry coverage includes a global perspective of all vertical and horizontal industries. Its unique coverage combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com

Vioxx Recall: Revenue Analysis and Impact on Cox-2 Inhibitor Markets

F135

The following is a list of key industry participants: Abgenix; Amgen; Bayer; Pfizer; Merck; Wyeth

Keywords in this release: Cox-2 inhibitors, Vioxx, United States, Food and Drug Administration, FDA, over-the-counter products, OTC, traditional non-steroidal anti-inflammatory drugs, NSAIDs, research, information, market, trends, technology, service, forecast

Frost & Sullivan North America Danielle White, 210-247-2403 fax: 210-348-1003 dwhite@frost.com or Europe Katja Feick, +44 (0) 20 7915 7856 fax: +44 (0) 20 7730 3343 katja.feick@frost.com or Asia Pacific Radhika Menon Theodore, +91 44 24314263, ext. 312 fax: +91 44 24314264 rmtheodore@frost.com http://www.frost.com

12/15/2004 07:45 ET

and here is how it works:

Hello Ginger,

Thanks for your response to the press release.  Please view the attached link below for the analysis overview (virtual brochure) for the Vioxx Recall: Revenue Analysis and Impact on Cox-2 Inhibitor Markets (just click on any of the links below the "FEATURES OF THE RESEARCH " section).

http://www.frost.com/prod/servlet/report-homepage.pag?repid=F135-01-00-00-00&ctxst=FcmCtx15&ctxht=FcmCtx16&ctxhl=FcmCtx17&ctxixpLink=FcmCtx18&ctxixpLabel=FcmCtx19
[see below]
(See attached file: F135 - Vioxx Recall - Cox-2 Inhibitor Markets.htm)

One of our account executives will also be in touch with you soon to provide details on how you can acquire the entire document.

Thanks,

Danielle White
Corporate Communications, Healthcare
North America Team Leader
Frost & Sullivan
http://www.frost.com/
t) 210-247-2403
f) 210-348-1003
e) dwhite@frost.com

How to Use this Service

Ways This Service Can Help Your Company Succeed

Craft a Strategic Business Plan

Use Frost & Sullivan's up-to-the-minute market measurements of competition and customer base not just your own sales to calibrate and refine your business plan. Your company is at great risk if you rely only on internal measurements.

Generate New Product Ideas

Tap Frost & Sullivan's "New Product Development" and "Market Strategy" sections to form a multidisciplinary task force to identify new product opportunities. Each task force member should read and analyze this report and be prepared to brainstorm possible new product ideas that could be created to better address the market.

Create an Action Plan to Be Proactive in the Market

Change your company's strategy from reacting to the market to becoming aggressively proactive in it. Create action plans to address each market, competitive, and technical trend this report covers.

Forge a Competitive Strategy to Build Your Market Share

Your task force's in-depth analysis of the competitor information covered in this report will provide insights that can help you gain market share or protect your current share from competitive attacks.

Design an Acquisition Strategy to Make Your Business Grow

Use this report to identify specific companies with complementary skills and assets that could make excellent acquisition targets to expand and improve your company.

Make Your Company Market Driven

A major challenge facing businesses today is to become market driven. Your company can use our reports to develop presentations to train all departments on your position in the market.

Establish a Market Monitoring Program

The key to success is being 100 percent aware of your company's market position with respect to customers and competition. This report can help you begin such a program.

Identify Customer Needs

This report can identify customer segments and needs that current competitors are not addressing properly. With this knowledge, you can design customer surveys fully delineating such segments and their corresponding needs.

Develop a Successful Product Launch Strategy

The strategy used to launch a new product can often make or break its profitability. To ensure success, you can use this report to identify market elements that must be addressed in the product launch strategy.

What Frost & Sullivan Offers Clients

World-Class Customer Service

Premier customer service is our goal. Every client is assigned an account executive to personally handle comments, orders and inquiries on any of our products or services.

Focus on Solutions

We focus on identifying and meeting our clients' needs, ensuring that the investment made in services from Frost & Sullivan will generate action and further goal attainment.

Return on Investment

Every aspect of our services is geared towards generating a significant return on your investment. The added value in our products and services puts them a step above the competition.

Customization

We can customize our services to fit our clients' needs. Training and research consultants will provide services to match our clients' specifications and budgets.

International Capabilities

In today's competitive markets, our clients need consultants who can cover the world. We can meet all your information and training needs through our offices worldwide.

Depth of Knowledge and Experience

Our consultants have in-depth knowledge and experience in the industries and technologies they cover, enabling thorough and accurate work.

Fast Response

We pride ourselves on the fast response we provide our clients, working to keep clients' strategies and plans on schedule.

Disciplined Methodology

All of the services we offer follow a rigorous research methodology, ensuring quality and customer satisfaction.

Extensive Industry Databases and Information Sources

We have maintained detailed and accurate information databases for 30 years on virtually every industry, product and region in the world. These are updated regularly to yield up-to-the-minute market intelligence.

Confidentiality

We safeguard our clients' projects with the highest standards of confidentiality and ethics in the marketing consulting and training industry.

Your Portal for Market Information

frost.com

gives you direct and secure access to all of Frost & Sullivan's market strategy and consulting analysis. You can now purchase single documents, segments, and chapters, or subscribe to research and strategy in a specific market to get the exact content you need to drive your winning business solutions.

Use

frost.com to support investment decisions, identify new market opportunities, and maximize your overall competitive position.

Our Markets

frost.com comprises vertical portals dedicated to specific industries, bringing you the latest market findings at no charge.

Added Benefits

Direct Interaction

Live web broadcasts of our expert industry analysts delivered straight to your PC.

Competitive Edge

Colleagues stay on top of latest market trends and competitors' advances.

Total Flexibility

Cut and paste text and color graphics into your presentations; save and send any information.

Real Time Delivery

View and purchase new content immediately after it has been posted.

Added Value for Your Money

Purchase single documents, segments, and chapters; subscribe to research and strategy in a focused market, or let us tailor your winning solutions.

Maximize Your Investment

Unlimited global access to content your company purchases.

Save Valuable Time

Improve accuracy and speed of strategic business decision-making.

 

 


Ahhhhhh . . . the power of advertising - no matter how inappropriate:

 
veterinaryalert@petsUnlimited.com wrote:
Ginger Sanchez, we have an important message concerning your veterinarian.

Your veterinarian in is listed in the PetsUnlimited.com veterinary directory but some of their information is incomplete.

Please call and remind your veterinarian that their information is incomplete in the PetsUnlimited.com veterinary directory, which is searched more than 17,000 times daily.

You can find their phone number here: Find Your Vet

They are missing their hours of operation, emergency hours, alternate emergency phone numbers, the names and bio's of all their care professionals, weekly pet tips, and other important information that you and new potential customers want and need.

Don't forget to make sure you have chosen your veterinarian in your PetsUnlimited.com profile. Simply log into your profile and click on the Manage My Veterinarian Options link.

Also, be sure to use the veterinary appointment reminder feature so you don't miss your next appointment. This feature is available from your PetsUnlimited.com profile page.

Sincerely,
Member Services
PetsUnlimited.com Inc.
http://www.petsunlimited.com

Do not reply to this email as we are unable to receive email at this address.
You have received this message as a member of PetsUnlimited.com and in compliance with our terms of service, user agreement, and all applicable laws.
Please see our privacy policy and profile preferences for more information or to update your email preferences.
You can log into your profile here
PetsUnlimited.com
Reston, VA 20195
Unfortunately, "my veterinarian" needlessly/senselessly caused my beloved dog's horrific death and is currently under investigation by the Washington State, Veterinary Board of Governors,  Case #: 2004-04-0008 VT. 
 
Hopefully, "updated information" will soon be found in  
Have a nice day -
Ginger Sanchez

 



May my beloved partner ROMI rest in peace  - no matter wherever her bits and pieces/frozen carcass may be held hostage.

                            

                  [what's in YOUR "urn" ?]

                 

This Website Built and Hosted for Free at
Bravenet.com